{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:52:38Z","timestamp":1791921158660,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07454-9","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:43:35Z","timestamp":1790732615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trajectory-based analysis of growth in congenital adrenal hyperplasia: therapeutic implications for final height preservation"],"prefix":"10.1007","volume":"185","author":[{"given":"Zuzanna","family":"Gawlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Gawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Tyrawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Starzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Janu\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"7454_CR1","doi-asserted-by":"publisher","unstructured":"Van der Grinten HLC, Speiser PW, Faisal Ahmed S, Arlt W, Auchus RJ, Falhammar H et al (2022) Congenital adrenal hyperplasia\u2014current insights in pathophysiology, diagnostics, and management vol 43.\u00a0https:\/\/doi.org\/10.1210\/endrev\/bnab016\u00a0","DOI":"10.1210\/endrev\/bnab016"},{"key":"7454_CR2","doi-asserted-by":"publisher","unstructured":"Storbeck\u00a0KH, Schiffer\u00a0L, Baranowski\u00a0 ES, Chortis\u00a0 V, Prete\u00a0 A, Barnard\u00a0 L, Gilligan\u00a0LC, Taylor\u00a0 AE, Idkowiak\u00a0 J, Arlt\u00a0 W, Shackleton CHL\u00a0 (2019) Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism. Endocr Rev 40(6):1605-1625.\u00a0https:\/\/doi.org\/10.1210\/er.2018-00262","DOI":"10.1210\/er.2018-00262"},{"key":"7454_CR3","doi-asserted-by":"publisher","unstructured":"Pijnenburg-Kleizen\u00a0KJ, Thomas\u00a0 CMG, Otten\u00a0 BJ, Roeleveld\u00a0 N, Claahsen-van der Grinten\u00a0 HL  (2019) Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty. J Pediatr Endocrinol Metab 32(10):1055\u20131063.\u00a0https:\/\/doi.org\/10.1515\/jpem-2019-0006","DOI":"10.1515\/jpem-2019-0006"},{"key":"7454_CR4","doi-asserted-by":"publisher","unstructured":"White\u00a0PC, Speiser\u00a0 PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21(3):245\u2013291.\u00a0https:\/\/doi.org\/10.1210\/edrv.21.3.0398","DOI":"10.1210\/edrv.21.3.0398"},{"key":"7454_CR5","doi-asserted-by":"publisher","unstructured":"Claahsen-van der Grinten\u00a0HL, Stikkelbroeck\u00a0NM, Otten\u00a0 BJ, Hermus\u00a0 AR (2011) Congenital adrenal hyperplasia\u2014pharmacologic interventions from the prenatal phase to adulthood. Pharmacol Ther 132(1):1\u201314.\u00a0https:\/\/doi.org\/10.1016\/j.pharmthera.2011.05.004","DOI":"10.1016\/j.pharmthera.2011.05.004"},{"issue":"6","key":"7454_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00431-005-0075-y","volume":"165","author":"A Balsamo","year":"2006","unstructured":"Balsamo A, Wasniewska M, Di Pasquale G, Salzano G, Baronio F, Bombaci S, De Luca F (2006) Birth length and weight in congenital adrenal hyperplasia according to the different phenotypes. Eur J Pediatr 165(6):380\u20133. https:\/\/doi.org\/10.1007\/s00431-005-0075-y","journal-title":"Eur J Pediatr"},{"key":"7454_CR7","doi-asserted-by":"publisher","unstructured":"Al-Rayess\u00a0H, Wiersma R, Turner\u00a0LE, Palzer E, Mercado Munoz Y, Sarafoglou K (2025) Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 110(7):e2198\u2013e2207.\u00a0https:\/\/doi.org\/10.1210\/clinem\/dgae771","DOI":"10.1210\/clinem\/dgae771"},{"key":"7454_CR8","doi-asserted-by":"crossref","unstructured":"Cutler\u00a0GB  Jr (1997) The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol 61(3\u20136):141\u2013144","DOI":"10.1016\/S0960-0760(97)80005-2"},{"key":"7454_CR9","doi-asserted-by":"publisher","unstructured":"Hochberg\u00a0Z (2002) Mechanisms of steroid impairment of growth. Horm Res 58(Suppl 1):33\u201338.\u00a0https:\/\/doi.org\/10.1159\/000064764","DOI":"10.1159\/000064764"},{"key":"7454_CR10","doi-asserted-by":"publisher","unstructured":"Speiser PW, Arlt\u00a0W, Auchus\u00a0 RJ, Baskin LS, Conway\u00a0 GS, Merke\u00a0DP, Meyer-Bahlburg\u00a0 HFL, Miller\u00a0 WL, Murad\u00a0MH, Oberfield\u00a0 SE, White\u00a0 PC (2018) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 103(11):4043\u2013 4088.\u00a0https:\/\/doi.org\/10.1210\/jc.2018-01865. Erratum in: J Clin Endocrinol Metab 2019 104(1):39\u201340. https:\/\/doi.org\/10.1210\/jc.2018\u201302371","DOI":"10.1210\/jc.2018-01865"},{"key":"7454_CR11","doi-asserted-by":"publisher","unstructured":"New\u00a0MI (2001) Factors determining final height in congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 14(Suppl 2):933\u2013937.\u00a0https:\/\/doi.org\/10.1515\/jpem-2001-s204","DOI":"10.1515\/jpem-2001-s204"},{"key":"7454_CR12","doi-asserted-by":"publisher","unstructured":"Liu X, Liu F, Qi Y, Han X, Ma S, Zheng R (2025) Combination therapy of GnRHa, RhGH and anastrozole to improve final adult height deficit in CAH children with CPP. BMC Pediatr 25(1):362.\u00a0https:\/\/doi.org\/10.1186\/s12887-025-05703-8","DOI":"10.1186\/s12887-025-05703-8"},{"key":"7454_CR13","doi-asserted-by":"publisher","unstructured":"Joint LWPES\/ESPE CAH Working Group (2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab  87(9):4048\u20134053.\u00a0\u00a0https:\/\/doi.org\/10.1210\/jc.2002-020611","DOI":"10.1210\/jc.2002-020611"},{"issue":"9","key":"7454_CR14","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS et al (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(9):4133\u20134160. https:\/\/doi.org\/10.1210\/jc.2009-2631","journal-title":"J Clin Endocrinol Metab"},{"key":"7454_CR15","doi-asserted-by":"publisher","unstructured":"Quintos JB, Vogiatzi MG, Harbison MD, New MI (2001) Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86(4):1511\u20131517.\u00a0https:\/\/doi.org\/10.1210\/jcem.86.4.7412","DOI":"10.1210\/jcem.86.4.7412"},{"key":"7454_CR16","doi-asserted-by":"publisher","unstructured":"Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI (2005) Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 90(6):3318\u201325.\u00a0https:\/\/doi.org\/10.1210\/jc.2004-2128","DOI":"10.1210\/jc.2004-2128"},{"key":"7454_CR17","doi-asserted-by":"publisher","unstructured":"Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG, New MI (2011) Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab 96(6):1710\u20131717.\u00a0https:\/\/doi.org\/10.1210\/jc.2010-2699","DOI":"10.1210\/jc.2010-2699"},{"key":"7454_CR18","doi-asserted-by":"publisher","unstructured":"Longui CA, Kochi C, Calliari LE, Modkovski MB, Soares M, Alves EF, Prudente FV, Monte O (2011) Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa. Arq Bras Endocrinol Metabol 55(8):661\u2013664.\u00a0https:\/\/doi.org\/10.1590\/s0004-27302011000800023","DOI":"10.1590\/s0004-27302011000800023"},{"key":"7454_CR19","doi-asserted-by":"publisher","unstructured":"Wit JM (2021) Should skeletal maturation be manipulated for extra height gain? Front Endocrinol (Lausanne) 12:812196.\u00a0https:\/\/doi.org\/10.3389\/fendo.2021.812196","DOI":"10.3389\/fendo.2021.812196"},{"key":"7454_CR20","doi-asserted-by":"publisher","unstructured":"Gidl\u00f6f S, Hogling DE, L\u00f6nnberg H, Ritz\u00e9n M, Lajic S, Nordenstr\u00f6m A (2024) Growth and treatment in congenital adrenal hyperplasia: an observational study from diagnosis to final height. Horm Res Paediatr 97(5):445\u2013455.\u00a0https:\/\/doi.org\/10.1159\/000535403","DOI":"10.1159\/000535403"},{"key":"7454_CR21","doi-asserted-by":"publisher","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, Sun L, Zaidi M, Wilson RC, Yuen T (2013) Genotype\u2013phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 110(7):2611\u20132616.\u00a0https:\/\/doi.org\/10.1073\/pnas.1300057110","DOI":"10.1073\/pnas.1300057110"},{"key":"7454_CR22","unstructured":"Palczewska I, Niedzwiedzka Z (2001) Wska\u017aniki rozwoju somatycznego dzieci I m\u0142odziezy Warszawskiej [Somatic development indices in children and youth of Warsaw]. Med Wieku Rozwoj. 5(2 Suppl 1):18\u2013118"},{"issue":"3","key":"7454_CR23","doi-asserted-by":"publisher","first-page":"E382","DOI":"10.15167\/2421-4248\/jpmh2025.66.3.3455","volume":"66","author":"E Rafiei","year":"2025","unstructured":"Rafiei E, Rouhani F, Bayat E, Moeini Z, Dehnavi N (2025) Final heights in patients with congenital adrenal hyperplasia: a retrospective cohort study. J Prev Med Hyg 66(3):E382\u2013E390. https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2025.66.3.3455","journal-title":"J Prev Med Hyg"},{"key":"7454_CR24","doi-asserted-by":"crossref","unstructured":"Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ, Montori VM (2010) Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab 95(9):4161\u20134172","DOI":"10.1210\/jc.2009-2616"},{"key":"7454_CR25","doi-asserted-by":"publisher","unstructured":"Lawrence NR, Bacila I, Tonge J, Balagamage C, Dawson J, Collins GS, Lang ZQ, Bryce J, Alimussina M, Chen M, Ali SR, Amin N, Amr NH, Anverdeen FA, Bachega T, Banaszak-Ziemska M, Baronio F, Birkeb\u00e6k NH, Bonfig W, Clemente-Le\u00f3n M, Cools M, Davies JH, de Vries L, de Bruin C, Elsedfy H, Fl\u00fcck CE, Fu A, Gazdagh G, German A, Gevers E, Globa E, G\u00fcven A, Hannema SE, Iotova V, Janus D, El Kaddouri H, van der Kamp HJ, Krone R, Lenherr-Taube N, Marginean O, Markosyan R, Mazen I, Miles H, de Miranda MC, Mohnike KL, Morris C, Natarajan A, Neumann U, Niedziela M, Ortolano R, Perez AF, Poyrazo\u011flu \u015e, Probst-Scheidegger U, Randell T, Rees DA, Russo G, Salerno M, De Sanctis L, Schwitzgebel Luscher V, Seneviratne SN, Shenoy S, Shnorhavorian M, Stancampiano MR, Tadokoro-Cuccaro R, Thankamony A, Utari A, Vieites A, Wasniewska M, Yeste D, Tomlinson JW, Ahmed SF, Krone N (2026) Adiposity rebound and height velocity in patients with congenital adrenal hyperplasia. Eur J Endocrinol.\u00a0https:\/\/doi.org\/10.1093\/ejendo\/lvag050","DOI":"10.1093\/ejendo\/lvag050"},{"key":"7454_CR26","doi-asserted-by":"publisher","unstructured":"Troger T, Sommer G, Lang-Muritano M, Konrad D, Kuhlmann B, Zumsteg U, Fl\u00fcck CE (2022) Characteristics of growth in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency during adrenarche and beyond. J Clin Endocrinol Metab 107(2):e487\u2013e499.\u00a0https:\/\/doi.org\/10.1210\/clinem\/dgab701","DOI":"10.1210\/clinem\/dgab701"},{"key":"7454_CR27","doi-asserted-by":"crossref","unstructured":"Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51(3):170\u2013179","DOI":"10.1136\/adc.51.3.170"},{"key":"7454_CR28","doi-asserted-by":"publisher","unstructured":"Bhullar G, Tanawattanacharoen VK, Yeh MY, Kim WS, Vidmar AP, Geffner ME, Hwang DH, Kim MS (2020) Early adiposity rebound predicts obesity and adiposity in youth with congenital adrenal hyperplasia. Horm Res Paediatr 93(11\u201312):609\u2013615.\u00a0https:\/\/doi.org\/10.1159\/000514130","DOI":"10.1159\/000514130"},{"issue":"1","key":"7454_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01671-4","volume":"50","author":"AL Pomi","year":"2024","unstructured":"Pomi AL, Pepe G, Aversa T, Corica D, Valenzise M, Messina MF, Morabito LA, Stagi S, Wasniewska M (2024) Early adiposity rebound: predictors and outcomes. Ital J Pediatr 50(1):98. https:\/\/doi.org\/10.1186\/s13052-024-01671-4","journal-title":"Ital J Pediatr"},{"key":"7454_CR30","doi-asserted-by":"publisher","unstructured":"Liu SC, Suresh M, Jaber M, Mercado Munoz Y, Sarafoglou K (2023) Case report: anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia. Front Endocrinol (Lausanne) 14:1101843.\u00a0https:\/\/doi.org\/10.3389\/fendo.2023.1101843","DOI":"10.3389\/fendo.2023.1101843"},{"key":"7454_CR31","doi-asserted-by":"publisher","unstructured":"Balsamo A, Cicognani A, Baldazzi L, Barbaro M, Baronio F, Gennari M, Bal M, Cassio A, Kontaxaki K, Cacciari E (2003) CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency. J Clin Endocrinol Metab 88(12):5680\u20135688.\u00a0https:\/\/doi.org\/10.1210\/jc.2003-030123","DOI":"10.1210\/jc.2003-030123"},{"key":"7454_CR32","doi-asserted-by":"crossref","unstructured":"Kuhnle U, R\u00f6sler A, Pareira JA, Gunzcler P, Levine LS, New MI (1983) The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency. Acta Endocrinol 102(4):577\u2013582","DOI":"10.1530\/acta.0.1020577"},{"key":"7454_CR33","doi-asserted-by":"publisher","unstructured":"Mallappa A, Merke DP (2022) Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat Rev Endocrinol 18(6):337\u2013352.\u00a0https:\/\/doi.org\/10.1038\/s41574-022-00655-w","DOI":"10.1038\/s41574-022-00655-w"},{"issue":"1","key":"7454_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-025-06673-w","volume":"185","author":"R Paparella","year":"2025","unstructured":"Paparella R, Panvino F, Pucarelli I, Niceta M, Spaziani M, Spalice A, Pisani F, Ardizzone I, Tarani L (2025) Beyond endocrine features in non-classical congenital adrenal hyperplasia: a narrative review of psychoneuro-social perspectives in pediatric and adolescent patients. Eur J Pediatr 185(1):11. https:\/\/doi.org\/10.1007\/s00431-025-06673-w","journal-title":"Eur J Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07454-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07454-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07454-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:37:27Z","timestamp":1791920247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07454-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["7454"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07454-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"788"}}